The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Direct-acting antivirals (DAAs) achieve high hepatitis C virus (HCV) cure rates and are forgiving to missed doses, but adherence–efficacy relationships have not been well defined. Traditional adherence measures (e.g. pill counts, self-report and pharmacy refills) over-estimate medication adherence....

Descripción completa

Detalles Bibliográficos
Autores principales: Adje, Yeba H., Brooks, Kristina M., Castillo-Mancilla, Jose R., Wyles, David L., Anderson, Peter L., Kiser, Jennifer J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Infections Associated with Substance Use and Related Behaviors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112320/
https://www.ncbi.nlm.nih.gov/pubmed/35591885
http://dx.doi.org/10.1177/20499361221095664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112320/
https://www.ncbi.nlm.nih.gov/pubmed/35591885
http://dx.doi.org/10.1177/20499361221095664

Ejemplares similares